Medical Devices

Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms and Services), By Application (Diagnostics, Biomarkers and Cancer, Reproductive Health), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Other Technologies) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL1177708
  • 162 Pages
  • April 2017
  • Medical Devices

Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. The global next generation sequencing market accounted for $3,567 million in 2015, and is anticipated to reach $12,801 million by 2022, registering a CAGR of 19.9% from 2016 to 2022. NGS also known as deep sequencing and parallel sequencing is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method. Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes, and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.  

Technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs drives the global next generation sequencing market. In addition, rise in awareness pertaining to next generation sequencing and rise in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to next generation sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and untapped emerging economies offer lucrative opportunities for the market players.

The next generation sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, the market is segmented into consumables, platforms, and services. The consumables product segment is further classified on the basis of sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment and quality control. The platform NGS product segment is bifurcated into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management. In the NGS product segment, consumables occupied dominant share in 2015, and the segment is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of NGS.

Based on application, this market is bifurcated into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, and other applications. The biomarkers & cancer application was the highest revenue contributor in 2015, while the personalized medicine segment is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D throughout the world along with surge in awareness about NGS applications in precision medicine. Based on technology, the next generation sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. Sequencing by synthesis technology held the greatest share in 2015 and this trend is estimated to continue throughout the study period as this technology allows both short and long insert paired end reads for high resolution genome sequencing and structural variation detection, sequence assembly & others respectively..

Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next generation sequencing market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of NGS in this region. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize NGS in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global next generation sequencing market.

KEY PLAYERS PROFILED

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • Beijing Genomics Institute
  • Qiagen N.V.
  • 454 Life Sciences Corporation (Roche Holding AG)
  • Agilent Technologies, Inc.
  • Perkinelmer, Inc.
  • Genomatix GmbH
  • PierianDx.

KEY MARKET BENEFITS

  • The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market for the period of 2014‐2022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product type assists in understanding the trends in the industry.
  • Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry

Next generation sequencing Market Key Segments:

By Product

  • Consumables
    • Sample Preparation Consumables
      • DNA Fragmentation, End Repair, A-Tailing and Size Selection
      • Library Preparation & Target Enrichment
      • Quality Control
    • Other Consumables
  • Platforms
    • HiSeq
    • MiSeq
    • Ion Torrent
    • SOLiD
    • Pacbio Rs II and Sequel System
    • Other Sequencing Platforms
  • Services
    • Sequencing Services
      • RNA Sequencing
      • Whole Exome Sequencing
      • Whole Genome Sequencing
      • Targeted Sequencing
      • Chip Sequencing
      • De Novo Sequencing
      • Methyl Sequencing
    • Data Management Services
      • NGS Data Analysis Services
      • NGS Data Analysis Software & Workbenches
      • NGS Storage, Management and Cloud Computing Solutions

By Application

  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Agriculture and Animal Research
  • Other Applications

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single Molecule Real Time Sequencing
  • Other Technologies

By End User    

  • Academic & Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals & Clinics    

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Other players in the value chain include (profiles not included in the report)

  • Eurofins Scientific
  • Gatc Biotech AG
  • Macrogen, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Bio-Rad Laboratories, Inc.
  • DNASTAR, Inc.
  • Biomatters Ltd.
  • Partek Inc.
  • New England Biolabs, Inc.
  • Myriad Genetics, Inc.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.

July 2017 | $5370 | Pre Book Price:$4699

World Anti-Snoring Devices and Snoring Surgery Market - Opportunities and Forecasts, 2014 - 2020

The anti-snoring devices and snoring surgery market has gained traction in the recent years due to growing consciousness about the ill effects of snoring and sleep apnea, and these treatments ...

July 2017 | $5370 | Pre Book Price:$4699

World Sports Medicine Market - Opportunities and Forecasts, 2014 - 2020

The sports medicine market consists of products used by athletes or sportspersons to prevent injuries and protect themselves including devices that boost performance. The product offerings play a crucial role in the rehabilitation, recovery, endurance, and monitoring of athletes in sports.

July 2017 | $5370 | Pre Book Price:$4699

World 3D Printing Medical Devices Market - Opportunities and Forecasts, 2014 - 2020

Large patient population, expansion of distribution networks by the key market players, awareness about benefits of 3D printing technology and its adoption across the emerging countries in Asia-Pacific are the ...

July 2017 | $5370 | Pre Book Price:$4699

World Veterinary Imaging Market - Opportunities and Forecasts, 2014 - 2020

Veterinary diagnostic imaging consists of a non-invasive method of obtaining images of the animal body for the purpose of medical diagnostics. The animals considered for imaging are small companion animals, ...

July 2017 | $5370 | Pre Book Price:$4699

BRIC Diabetes Care Devices Market - Opportunities and Forecasts, 2014 - 2020

Diabetes care devices helps in the management of blood glucose levels caused in patients due to inadequate insulin production or insulin resistance. The Diabetes Care Devices Market in Brazil, Russia, ...

July 2017 | $5370 | Pre Book Price:$4699

2017 © Copyright Big Market Research

View Pricing >>